HealthCor Management, L.P. Buys Medtronic PLC, Danaher Corp, Anthem Inc, Sells Bristol-Myers Squibb Co, McKesson Corp, Welltower Inc

Author's Avatar
Feb 16, 2022
Article's Main Image
New York, NY, based Investment company HealthCor Management, L.P. (Current Portfolio) buys Medtronic PLC, Danaher Corp, Anthem Inc, Johnson & Johnson, Health Care Select Sector SPDR, sells Bristol-Myers Squibb Co, McKesson Corp, Welltower Inc, Horizon Therapeutics PLC, Zimmer Biomet Holdings Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, HealthCor Management, L.P.. As of 2021Q4, HealthCor Management, L.P. owns 68 stocks with a total value of $1.8 billion. These are the details of the buys and sells.

For the details of HealthCor Management, L.P.'s stock buys and sells, go to https://www.gurufocus.com/guru/healthcor+management%2C+l.p./current-portfolio/portfolio

These are the top 5 holdings of HealthCor Management, L.P.
  1. Medtronic PLC (MDT) - 1,530,580 shares, 8.62% of the total portfolio. Shares added by 149.90%
  2. Bristol-Myers Squibb Co (BMY) - 1,804,550 shares, 6.12% of the total portfolio. Shares reduced by 49.65%
  3. Biogen Inc (BIIB) - 453,400 shares, 5.92% of the total portfolio. Shares reduced by 2.88%
  4. Horizon Therapeutics PLC (HZNP) - 832,270 shares, 4.88% of the total portfolio. Shares reduced by 34.89%
  5. Envista Holdings Corp (NVST) - 1,642,680 shares, 4.03% of the total portfolio. Shares reduced by 26.99%
New Purchase: Danaher Corp (DHR)

HealthCor Management, L.P. initiated holding in Danaher Corp. The purchase prices were between $292.08 and $329.01, with an estimated average price of $311.04. The stock is now traded at around $266.165200. The impact to a portfolio due to this purchase was 2.7%. The holding were 150,590 shares as of 2021-12-31.

New Purchase: Anthem Inc (ANTM)

HealthCor Management, L.P. initiated holding in Anthem Inc. The purchase prices were between $370.08 and $467.67, with an estimated average price of $421.99. The stock is now traded at around $453.265000. The impact to a portfolio due to this purchase was 2.56%. The holding were 101,560 shares as of 2021-12-31.

New Purchase: Health Care Select Sector SPDR (XLV)

HealthCor Management, L.P. initiated holding in Health Care Select Sector SPDR. The purchase prices were between $124.86 and $141.49, with an estimated average price of $132.44. The stock is now traded at around $129.810000. The impact to a portfolio due to this purchase was 1.95%. The holding were 254,230 shares as of 2021-12-31.

New Purchase: The Cooper Companies Inc (COO)

HealthCor Management, L.P. initiated holding in The Cooper Companies Inc. The purchase prices were between $373.53 and $434.12, with an estimated average price of $407.06. The stock is now traded at around $397.600000. The impact to a portfolio due to this purchase was 1.83%. The holding were 80,130 shares as of 2021-12-31.

New Purchase: Abbott Laboratories (ABT)

HealthCor Management, L.P. initiated holding in Abbott Laboratories. The purchase prices were between $115.53 and $141.46, with an estimated average price of $128.29. The stock is now traded at around $123.040000. The impact to a portfolio due to this purchase was 1.55%. The holding were 202,710 shares as of 2021-12-31.

New Purchase: Humana Inc (HUM)

HealthCor Management, L.P. initiated holding in Humana Inc. The purchase prices were between $384.96 and $469.02, with an estimated average price of $443.48. The stock is now traded at around $424.245000. The impact to a portfolio due to this purchase was 1.38%. The holding were 54,640 shares as of 2021-12-31.

Added: Medtronic PLC (MDT)

HealthCor Management, L.P. added to a holding in Medtronic PLC by 149.90%. The purchase prices were between $99.53 and $127.75, with an estimated average price of $115.4. The stock is now traded at around $102.070000. The impact to a portfolio due to this purchase was 5.17%. The holding were 1,530,580 shares as of 2021-12-31.

Added: Johnson & Johnson (JNJ)

HealthCor Management, L.P. added to a holding in Johnson & Johnson by 3743.54%. The purchase prices were between $155.93 and $173.01, with an estimated average price of $163.78. The stock is now traded at around $166.580000. The impact to a portfolio due to this purchase was 2.53%. The holding were 279,810 shares as of 2021-12-31.

Added: Revance Therapeutics Inc (RVNC)

HealthCor Management, L.P. added to a holding in Revance Therapeutics Inc by 1678.94%. The purchase prices were between $12.46 and $27.3, with an estimated average price of $16.46. The stock is now traded at around $13.500000. The impact to a portfolio due to this purchase was 1.22%. The holding were 1,449,835 shares as of 2021-12-31.

Added: Immunogen Inc (IMGN)

HealthCor Management, L.P. added to a holding in Immunogen Inc by 555.17%. The purchase prices were between $4.75 and $7.5, with an estimated average price of $6.22. The stock is now traded at around $5.515000. The impact to a portfolio due to this purchase was 0.45%. The holding were 1,310,340 shares as of 2021-12-31.

Added: Veracyte Inc (VCYT)

HealthCor Management, L.P. added to a holding in Veracyte Inc by 141.16%. The purchase prices were between $36.09 and $53.79, with an estimated average price of $44.05. The stock is now traded at around $29.280000. The impact to a portfolio due to this purchase was 0.16%. The holding were 119,710 shares as of 2021-12-31.

Added: Incyte Corp (INCY)

HealthCor Management, L.P. added to a holding in Incyte Corp by 44.07%. The purchase prices were between $63.34 and $74.11, with an estimated average price of $67.48. The stock is now traded at around $67.860000. The impact to a portfolio due to this purchase was 0.13%. The holding were 108,050 shares as of 2021-12-31.

Sold Out: Welltower Inc (WELL)

HealthCor Management, L.P. sold out a holding in Welltower Inc. The sale prices were between $79.36 and $87.07, with an estimated average price of $83.41.

Sold Out: Zimmer Biomet Holdings Inc (ZBH)

HealthCor Management, L.P. sold out a holding in Zimmer Biomet Holdings Inc. The sale prices were between $118.89 and $151.03, with an estimated average price of $134.39.

Sold Out: Cigna Corp (CI)

HealthCor Management, L.P. sold out a holding in Cigna Corp. The sale prices were between $191.9 and $231.65, with an estimated average price of $212.85.

Sold Out: Ventas Inc (VTR)

HealthCor Management, L.P. sold out a holding in Ventas Inc. The sale prices were between $45.69 and $56.9, with an estimated average price of $52.13.

Sold Out: Becton, Dickinson and Co (BDX)

HealthCor Management, L.P. sold out a holding in Becton, Dickinson and Co. The sale prices were between $235.83 and $257.21, with an estimated average price of $245.62.

Sold Out: Align Technology Inc (ALGN)

HealthCor Management, L.P. sold out a holding in Align Technology Inc. The sale prices were between $589.61 and $711.02, with an estimated average price of $642.97.

Reduced: Bristol-Myers Squibb Co (BMY)

HealthCor Management, L.P. reduced to a holding in Bristol-Myers Squibb Co by 49.65%. The sale prices were between $53.63 and $62.52, with an estimated average price of $58.67. The stock is now traded at around $67.760000. The impact to a portfolio due to this sale was -4.54%. HealthCor Management, L.P. still held 1,804,550 shares as of 2021-12-31.

Reduced: McKesson Corp (MCK)

HealthCor Management, L.P. reduced to a holding in McKesson Corp by 85.52%. The sale prices were between $198.21 and $248.9, with an estimated average price of $220.27. The stock is now traded at around $274.970000. The impact to a portfolio due to this sale was -3.26%. HealthCor Management, L.P. still held 64,070 shares as of 2021-12-31.



Here is the complete portfolio of HealthCor Management, L.P.. Also check out:

1. HealthCor Management, L.P.'s Undervalued Stocks
2. HealthCor Management, L.P.'s Top Growth Companies, and
3. HealthCor Management, L.P.'s High Yield stocks
4. Stocks that HealthCor Management, L.P. keeps buying
Rating:
NaN / 5 ( votes)
Author's Avatar
WRITTEN BY

GuruFocus Screeners

Related Articles